Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
AUROLAB Stock Analysis
Views
Red Flags
Positive
Not enough talking point with positive stance
Negative
Expensive and at a premium to industry median P/E
Low and declining ROE
Moderate operating margin but declining trend
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Reasonable Debt to Equity, and has been stable
Company's earnings are of moderate quality
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.125492.
Snapshot
See detailed analysis
AUROLAB Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
AUROLAB Bulk, Block & Insider Trades
AUROLAB Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Auro Laboratories Limited is an India-based company, which is engaged in the manufacturing activities of active pharmaceutical ingredients (APIs). The Company is specializing in producing anti-diabetics like Metformin HCL, which is used in the treatment of type 2 diabetes. It also undertakes toll/cu... Read More
Key personnel
Sharat DeorahD
Executive Chairman of the Board, Managing Director
Mr. Kuntal Pancholi
Chief Financial Officer
Ms. Padma Tapariya
Compliance Officer, Company Secretary
Siddhartha DeorahD
Whole-Time Director
Mr. Kiran KulkarniD
Whole Time Director
Mr. Mahendra Kumar DagaD
Additional Non-Executive Independent Director
Mr. Vishal Kailashchandra JhunjhunwalaD
Additional Non-Executive Independent Director
Mrs. Kavita Vijayakant SharmaD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Auro Laboratories Ltd.?
The current share price of Auro Laboratories Ltd. is ₹ 225.40 as of 09 Jan 2026.
What is the PE ratio of Auro Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Auro Laboratories Ltd. is 104.97 as of the latest financial data.
What is the ROE and ROCE of Auro Laboratories Ltd.?
Auro Laboratories Ltd. has a Return on Equity (ROE) of 3.08% and a Return on Capital Employed (ROCE) of 2.95% as per the latest financial reports.
What is the market cap of Auro Laboratories Ltd.?
The market capitalization of Auro Laboratories Ltd. stands at ₹ 140.49 Cr.
What is the dividend yield of Auro Laboratories Ltd.?
The dividend yield of Auro Laboratories Ltd. is 0.00% based on the current market price.
What is the RSI of Auro Laboratories Ltd.?
The Relative Strength Index (RSI) of Auro Laboratories Ltd. is 36.68.
What is the FII and DII holding in Auro Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.01% of Auro Laboratories Ltd. shares.
What sector does Auro Laboratories Ltd. belong to?
Auro Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Auro Laboratories Ltd. stock?
The beta of Auro Laboratories Ltd. stock is 0.80, indicating its volatility relative to the broader market.
